JP6712715B2 - 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途 - Google Patents

結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途 Download PDF

Info

Publication number
JP6712715B2
JP6712715B2 JP2016505515A JP2016505515A JP6712715B2 JP 6712715 B2 JP6712715 B2 JP 6712715B2 JP 2016505515 A JP2016505515 A JP 2016505515A JP 2016505515 A JP2016505515 A JP 2016505515A JP 6712715 B2 JP6712715 B2 JP 6712715B2
Authority
JP
Japan
Prior art keywords
composition
corn fiber
linear
soluble corn
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016505515A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016515388A (ja
JP2016515388A5 (enExample
Inventor
マリー ウィーヴァー コニー
マリー ウィーヴァー コニー
エイチ． ナカツ シンディ
エイチ． ナカツ シンディ
ウィリアムソン パトリシア
ウィリアムソン パトリシア
ジョゼフ ホフマン アンドルー
ジョゼフ ホフマン アンドルー
マール サンダーズ リサ
マール サンダーズ リサ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Primary Products Ingredients Americas LLC
Original Assignee
Purdue Research Foundation
Tate and Lyle Ingredients Americas LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49081352&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6712715(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Purdue Research Foundation, Tate and Lyle Ingredients Americas LLC filed Critical Purdue Research Foundation
Publication of JP2016515388A publication Critical patent/JP2016515388A/ja
Publication of JP2016515388A5 publication Critical patent/JP2016515388A5/ja
Application granted granted Critical
Publication of JP6712715B2 publication Critical patent/JP6712715B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2016505515A 2013-03-22 2014-03-22 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途 Active JP6712715B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361804584P 2013-03-22 2013-03-22
US61/804,584 2013-03-22
PCT/US2014/031526 WO2014153554A1 (en) 2013-03-22 2014-03-22 Uses of soluble corn fiber for increasing colonic bacteria populations and increasing mineral absorption

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020074299A Division JP7055162B2 (ja) 2013-03-22 2020-04-17 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途

Publications (3)

Publication Number Publication Date
JP2016515388A JP2016515388A (ja) 2016-05-30
JP2016515388A5 JP2016515388A5 (enExample) 2017-04-27
JP6712715B2 true JP6712715B2 (ja) 2020-06-24

Family

ID=49081352

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016505515A Active JP6712715B2 (ja) 2013-03-22 2014-03-22 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途
JP2020074299A Active JP7055162B2 (ja) 2013-03-22 2020-04-17 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020074299A Active JP7055162B2 (ja) 2013-03-22 2020-04-17 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途

Country Status (8)

Country Link
US (2) US11129403B2 (enExample)
EP (2) EP2981180B2 (enExample)
JP (2) JP6712715B2 (enExample)
KR (1) KR102362975B1 (enExample)
CN (2) CN114468303A (enExample)
ES (1) ES2909102T3 (enExample)
GB (1) GB201312713D0 (enExample)
WO (1) WO2014153554A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10039777B2 (en) 2012-03-20 2018-08-07 Neuro-Lm Sas Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
GB201312713D0 (en) 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
WO2019055717A1 (en) * 2017-09-13 2019-03-21 Evolve Biosystems, Inc. OLIGOSACCHARIDE COMPOSITIONS AND THEIR USE DURING THE TRANSIENT PHASES OF INTESTINAL MICROBIOMA OF A MAMMALIAN
WO2019106620A1 (en) * 2017-11-30 2019-06-06 Glycom A/S Human milk oligosaccharides and synthetic compositions thereof for microbiota modulation
CN115103605B (zh) * 2019-10-14 2025-03-14 泰特&莱尔解决方案美国公司 风味改变和/或甜度增强组合物和方法以及基于其的食品和饮料产品
WO2022271817A1 (en) * 2021-06-22 2022-12-29 Muhammed Majeed Calebin-a for thermogenesis and dysbiosis
JPWO2023176951A1 (enExample) 2022-03-18 2023-09-21
CA3248063A1 (en) 2022-05-06 2023-11-09 Tate & Lyle Solutions Usa Llc CHEWABLE CANDIES HIGH IN FIBER AND LOW IN SUGAR
CN120699879A (zh) * 2025-09-01 2025-09-26 美益添生物医药(武汉)有限公司 副普雷沃氏菌的增菌剂、增菌培养基及应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110477A (en) 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
JPS61219392A (ja) 1985-03-25 1986-09-29 Showa Sangyo Kk 高温度縮合反応による分岐オリゴ糖シラツプの製造方法
JPS63109791A (ja) 1986-10-27 1988-05-14 Showa Sangyo Co Ltd 分岐オリゴ糖シラツプの連続的製法
JP2779963B2 (ja) 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
JPH03175989A (ja) 1989-12-01 1991-07-31 Chiyoda Corp 分岐オリゴ糖シラップ及びその製造方法
US6023797A (en) * 1997-04-01 2000-02-15 Brumfield; John David Comfort beach towel with inflatable pillow
US6645506B1 (en) 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6811786B1 (en) 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
US6942754B2 (en) 1999-03-23 2005-09-13 Oji Paper Co., Ltd. Process for producing xylooligosaccharide from lignocellulose pulp
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US20030077255A1 (en) * 2001-04-16 2003-04-24 Sabharwal Hemant K. Compositions of bacteria and alpha-lactalbumin and uses thereof
CN100415894C (zh) 2001-04-27 2008-09-03 株式会社林原生物化学研究所 异麦芽糖的制备方法及用途
JP2005508647A (ja) 2001-11-12 2005-04-07 マーズ　インコーポレイテッド 食品
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
US20050271643A1 (en) 2003-08-14 2005-12-08 Iryna Sorokulova Bacterial strains, compositions including same and probiotic use thereof
US7759105B2 (en) 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20050095350A1 (en) 2003-09-22 2005-05-05 Grain Processing Corporation Nutritive food source including controlled energy release carbohydrate
GB0414655D0 (en) 2004-06-30 2004-08-04 Leuven K U Res & Dev Prebiotic
US20060210696A1 (en) † 2005-03-17 2006-09-21 Chi-Li Liu Slowly digestible carbohydrate
CN101291597A (zh) * 2005-10-24 2008-10-22 雀巢技术公司 膳食纤维制剂和施用方法
JP5030960B2 (ja) * 2005-10-24 2012-09-19 ネステク ソシエテ アノニム 食物繊維製剤及び投与方法
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
US7608436B2 (en) * 2006-01-25 2009-10-27 Tate & Lyle Ingredients Americas, Inc. Process for producing saccharide oligomers
FR2897869B1 (fr) † 2006-02-28 2011-05-06 Roquette Freres Polymeres solubles de glucose hautement branches pour la nutrition enterale, parenterale et pour la dialyse peritoneale
CN101095698B (zh) 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
US20080254166A1 (en) * 2007-01-25 2008-10-16 Potter Susan M Food Additives Containing Combinations of Prebiotics and Probiotics
AU2008256938B2 (en) † 2007-05-23 2013-02-28 Tate & Lyle Ingredients Americas Llc Edible composition comprising a slowly digestible or digestion resistant oligosaccharide composition
CN101492997A (zh) * 2008-01-21 2009-07-29 姚小林 液压潜孔凿岩冲击器
WO2010015580A1 (en) 2008-08-04 2010-02-11 Dsm Ip Assets B.V. Production of beadlets comprising probiotic compounds
CN101744239A (zh) 2008-12-01 2010-06-23 青岛东海药业有限公司 膳食纤维在制备防治便臭或便臭中毒综合征制剂中的应用
GB0903016D0 (en) * 2009-02-23 2009-04-08 Univ Gent Method for alleviating intestinal problems and novel bacterial strains therefor
CN101537020B (zh) 2009-04-24 2012-05-02 东北制药集团公司沈阳第一制药厂 地衣芽孢杆菌与寡糖类益生元的合生元及其组合物和制剂
US20120129794A1 (en) * 2009-07-24 2012-05-24 Dowd Scot E Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
WO2011043654A1 (en) * 2009-10-05 2011-04-14 Aak Patent B.V. Methods for diagnosing irritable bowel syndrome
PH12012500687A1 (en) * 2009-11-12 2012-10-29 Nestec Sa Nutritional composition for promoting gut microbiota balance and health
AU2011223002B2 (en) * 2010-03-01 2015-07-02 Institut National De La Recherche Agronomique Method of diagnostic of obesity
US9386793B2 (en) * 2010-08-20 2016-07-12 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
CN103068254A (zh) * 2010-08-25 2013-04-24 泰特&莱尔组分美国公司 合生素产品
WO2012089782A1 (en) * 2010-12-29 2012-07-05 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
EP2670770A2 (en) † 2011-02-03 2013-12-11 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. High molecular ordered fibrilar structures, method for their preparation and uses thereof
MX2014005433A (es) * 2011-11-04 2014-08-22 Gen Mills Inc Métodos y composiciones para modular bacterias gastrointestinales para promover la salud.
EP3686284A1 (en) * 2012-05-18 2020-07-29 Genome Research Limited Methods and groups
GB201312713D0 (en) 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption

Also Published As

Publication number Publication date
CN114468303A (zh) 2022-05-13
JP2016515388A (ja) 2016-05-30
KR20150135417A (ko) 2015-12-02
JP7055162B2 (ja) 2022-04-15
US11129403B2 (en) 2021-09-28
KR102362975B1 (ko) 2022-02-15
JP2020120675A (ja) 2020-08-13
US20220225654A1 (en) 2022-07-21
GB201312713D0 (en) 2013-08-28
EP4035734A1 (en) 2022-08-03
EP2981180A1 (en) 2016-02-10
EP2981180B2 (en) 2025-08-13
US20160058056A1 (en) 2016-03-03
WO2014153554A1 (en) 2014-09-25
EP2981180B1 (en) 2021-12-29
ES2909102T3 (es) 2022-05-05
CN105473004A (zh) 2016-04-06

Similar Documents

Publication Publication Date Title
JP7055162B2 (ja) 結腸バクテリア集団を増加させてミネラル吸収を増加させるための、可溶性コーンファイバーの用途
WO2017103019A1 (en) Mixture of hmos
JP2008504038A (ja) 前生物学的調製物
CN104684417A (zh) 用于负面情绪或内向性行为的预防性或疗效性治疗的产品
CN108778292A (zh) 包含肠膜明串珠菌产生的外泌多糖作为活性成分的用于预防或治疗代谢障碍的组合物
US20250197436A1 (en) Galactooligosaccharide composition
US20250312388A1 (en) Bifidobacterium infantis formulations
Van Loo Inulin-type fructans as prebiotics
Uyeno et al. Changes in mouse gastrointestinal microbial ecology with ingestion of kale
US20230034247A1 (en) Method and composition for treating or decreasing gut microbiome dysbiosis induced by a prior antibiotic treatment
Förster-Fromme et al. A new enzymatically produced 1-lactulose: a pilot study to test the bifidogenic effects
JP2024501148A (ja) Ｆ．プラウスニッツイ（Ｆ．ｐｒａｕｓｎｉｔｚｉｉ）の存在量を促進することにおいて使用するための２’－フコシルラクトース
Rastall Galacto‐oligosaccharides as prebiotic food ingredients
JP2024088889A (ja) 腸内細菌叢におけるＲｏｍｂｏｕｔｓｉａ属菌低減用組成物
CN116615117A (zh) 用于刺激普氏栖粪杆菌丰度的2’-岩藻糖基乳糖
HK40099493A (en) Oligosaccharide composition
Del Pozo de La Calle et al. Potential Effects of Sucralose and Saccharin on Gut Microbiota: A Review
JP2024152695A (ja) ビフィズス菌の増殖用組成物および増殖方法ならびに乳酸および／またはピルビン酸の増加用組成物および増加方法
Saville et al. Oligosaccharides Derived from Xylan, Arabinan, and Mannan
CN121013657A (zh) 用于在个体中使用以支持脑发育和/或认知发育的包含人乳低聚糖的组合物
JP2023167322A (ja) 抗ストレス剤及びリラックス剤
EP3431093A1 (en) Wheat-derived polysaccharides for reduction of antibiotic resistance
WO2025247520A1 (en) Synthetic carbohydrate composition
JP2025076880A (ja) がん関連疲労に対する抗疲労剤
GB2623335A (en) Compositions and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160229

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170322

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170322

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180604

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180903

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190325

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190624

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190816

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190925

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200123

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200319

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20200414

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200417

R150 Certificate of patent or registration of utility model

Ref document number: 6712715

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250